Date published: 2025-10-10

021-6093-6350

SCBT Portrait Logo
Seach Input

Rpn11 抑制因子

Rpn11, a subunit of the 19S regulatory particle of the 26S proteasome, plays a pivotal role in the ubiquitin-proteasome pathway. The ubiquitin-proteasome system is a key cellular machinery responsible for the degradation of misfolded or redundant proteins. Proteins targeted for degradation are first tagged with multiple ubiquitin molecules, creating a polyubiquitin chain. Rpn11's primary role is in the deubiquitination process, where it functions as a metalloprotease, cleaving the isopeptide bond between the polyubiquitin chain and the substrate protein. This deubiquitination is a prerequisite for substrate proteins to be unfolded and threaded into the core particle of the proteasome for degradation. Given the essential nature of this process for cellular proteostasis, Rpn11 is considered a crucial component of the ubiquitin-proteasome system.

Rpn11 inhibitors are chemical entities that specifically target and modulate the enzymatic activity of Rpn11. These inhibitors interact with the active site of Rpn11, often coordinating with the metal ion essential for its protease activity, leading to an obstruction in the deubiquitination process. The inhibition of Rpn11's function impedes the subsequent degradation of substrate proteins, leading to an accumulation of polyubiquitinated proteins. Given the precision of these inhibitors in targeting a specific step in the protein degradation pathway, they provide an intricate tool for researchers to dissect the biochemical and cellular consequences of interrupted proteasomal processing. By studying the effects of Rpn11 inhibitors, scientists can glean a deeper understanding of cellular protein homeostasis and the ramifications of its disruption.

関連項目

产品名称CAS #产品编号数量价格应用排名

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
¥1489.00
¥12004.00
115
(2)

硼替佐米是一种二肽硼酸类似物,主要作用于26S蛋白酶体,抑制其类似胰蛋白酶的活性。这会导致未降解的蛋白质堆积,从而诱导癌细胞凋亡。

Carfilzomib

868540-17-4sc-396755
5 mg
¥451.00
(0)

卡非佐米是一种环氧酮,可不可逆地与20S蛋白酶体的N端苏氨酸结合,抑制其类似胰蛋白酶的活性。它专门针对恶性细胞,对正常细胞则无影响。

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
¥3509.00
¥8112.00
(0)

伊沙佐米是一种硼酸类似物,一旦代谢,就会抑制20S蛋白酶体的类似胰蛋白酶的活性。这会破坏调节蛋白的降解,导致癌细胞凋亡。

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
¥1805.00
¥3385.00
(0)

Delanzomib是一种硼酸类20S蛋白酶体抑制剂。它主要抑制类似胰蛋白酶的活性,导致未降解的蛋白质在癌细胞中积聚并发生细胞凋亡。

Oprozomib

935888-69-0sc-477447
2.5 mg
¥3159.00
(0)

奥罗佐米是一种环氧酮,可选择性地抑制 20S 蛋白酶体的糜蛋白酶样活性。这会破坏蛋白质的平衡,导致恶性细胞凋亡。

ONX 0914

960374-59-8sc-477437
5 mg
¥2764.00
(0)

ONX-0914是一种环氧酮抑制剂,可选择性靶向免疫蛋白酶体亚基LMP7。它主要用于研究自身免疫性疾病,但也可以影响癌细胞的蛋白质降解。

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
¥632.00
¥2933.00
¥11056.00
163
(3)

MG132 是一种多肽醛,可逆性地抑制 20S 蛋白酶体的糜蛋白酶样活性。它能导致多泛素化蛋白质的积累,从而导致细胞凋亡。

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
¥1862.00
¥6487.00
60
(2)

乳清酸蛋白是一种天然产物,可不可逆地结合并抑制20S蛋白酶体。这种结合会导致泛素化蛋白的积累,从而诱导细胞周期停滞和细胞凋亡。

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
¥1512.00
¥2426.00
¥4964.00
¥5596.00
19
(2)

Epoxomicin是一种天然环氧酮,可选择性抑制20S蛋白酶体的类似胰蛋白酶的活性。这会导致多泛素化蛋白的积累,从而引发敏感细胞的凋亡。